Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoj Patel

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|November 26, 2019
Heterocycle amide isosteres: An approach to overcoming resistance for HIV-1 integrase strand transfer inhibitorsKevin M Peese, B Narasimhulu Naidu, Manoj Patel, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2014
Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitorsB Narasimhulu Naidu, Margaret E Sorenson, Manoj Patel, et al.
Epilepsia|June 9, 2016
SCN8A encephalopathy: Research progress and prospectsMiriam H Meisler, Guy Helman, Michael F Hammer, et al.
Journal of Medicinal Chemistry|January 5, 2019
5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site InhibitorsKevin M Peese, Christopher W Allard, Timothy Connolly, et al.
Bioorganic & Medicinal Chemistry|May 23, 2022
Scaffold modifications to the 4-(4,4-dimethylpiperidinyl) 2,6-dimethylpyridinyl class of HIV-1 allosteric integrase inhibitorsKyle Parcella, Manoj Patel, Yong Tu, et al.
Journal of Medicinal Chemistry|January 31, 2023
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one ScaffoldEric P Gillis, Kyle Parcella, Michael Bowsher, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase InhibitorKyle Parcella, Tao Wang, Kyle Eastman, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry Letters|November 26, 2019
Heterocycle amide isosteres: An approach to overcoming resistance for HIV-1 integrase strand transfer inhibitorsKevin M Peese, B Narasimhulu Naidu, Manoj Patel, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2014
Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitorsB Narasimhulu Naidu, Margaret E Sorenson, Manoj Patel, et al.
Epilepsia|June 9, 2016
SCN8A encephalopathy: Research progress and prospectsMiriam H Meisler, Guy Helman, Michael F Hammer, et al.
Journal of Medicinal Chemistry|January 5, 2019
5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site InhibitorsKevin M Peese, Christopher W Allard, Timothy Connolly, et al.
Bioorganic & Medicinal Chemistry|May 23, 2022
Scaffold modifications to the 4-(4,4-dimethylpiperidinyl) 2,6-dimethylpyridinyl class of HIV-1 allosteric integrase inhibitorsKyle Parcella, Manoj Patel, Yong Tu, et al.
Journal of Medicinal Chemistry|January 31, 2023
Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one ScaffoldEric P Gillis, Kyle Parcella, Michael Bowsher, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase InhibitorKyle Parcella, Tao Wang, Kyle Eastman, et al.
Pageof 3